ezCaretech
At a glance
ezCaretech filed 42 disclosures in the last 12 months, including 14 insider, 1 contract and 1 issuance. The most recent key filing was on Aug 14: Executive bought 1,999 sh on the market at an average ₩6,130, Jul 10–13.
Revenue for 2025 was ₩72.6B, up 6.9% on 2024. Operating margin was 3% against 0.3% a year earlier. Debt was 33% of equity at year end.
The 2025 annual report lists 471 employees with an average tenure of 6.4 years and average pay of ₩63.7M, #964 of 2,191 listed companies by average pay. Its 6 directors and auditors were paid ₩96M each on average. It paid no cash dividend for 2025. 서울대학교병원 and related parties held 35.48% at year end.
From the 2025 annual report
Staff: 471 (324 men, 147 women), of whom 13 on fixed-term contracts. Total pay for the year: ₩29.9B. Directors and auditors: 6, paid ₩574M in total.
No cash dividend was paid for 2025.
Largest shareholder
서울대학교병원 holds 32.86%; with 10 related parties the group holds 35.48% of common shares at year end (from 35.41% at the start of the year).
Auditor: 대주회계법인 · opinion: Unqualified.
Source: 2025 annual business report (DART). How figures are combined
New contracts, last 12 months
1 new supply contract worth 13% of the revenue stated in the filings.
Amended amounts replace the originals. Subsidiary contracts and terminations are excluded.
Financial summary
Key filings
Other filings
Links open the original filing on DART, in Korean.